Sanofi sheds dermatology unit for $423 million
December 19, 2011Manufacturing and Production, Sales and Marketing Canada, Dermik, Sanofi
Sanofi has completed the sale of its Canadian-based dermatology business Dermik for $422.5 million. The unit has been sold to …
EMA panel gives positive opinion for Roche’s Zelboraf
December 16, 2011Sales and Marketing EMA, Roche, Zelboraf
The EMA’s advisory committee is recommending the approval of Roche’s skin cancer drug Zelboraf. The European regulator’s Committee for Medicinal …
Best Moments of 2011
December 16, 2011Business Services, Medical Communications NHS, NHS reforms
Health Secretary Andrew Lansley was on the end of a verbal battering by GP and journalist Dr Phil Hammond on …
Amgen’s chief executive and chairman Kevin Sharer to retire
December 16, 2011Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Amgen
Kevin Sharer, Amgen’s chairman and chief executive, has announced his retirement next year, leading the way for Robert Bradway to …
Chandler Chicco acquires German comms firms
December 16, 2011Medical Communications Chandler Chicco, Haas & Health Partner Public Relations, SanCom Creative Communication Solutions.
Chandler Chicco Companies is to acquire German healthcare communication firms, Haas & Health Partner Public Relations and SanCom Creative Communication …
Merck and Roche begin combination hep C trial
December 16, 2011Research and Development, Sales and Marketing Copegus, Merck, Pegasys, Roche, Victrelis
Merck and Roche have started clinical trials to investigate combinations of their hepatitis C drugs. The first trial is designed …
BMS in cholesterol alliance with China’s Simcere
December 16, 2011Sales and Marketing BMS, CETP inhibitor, Simcere, cardiovascular, emerging markets
Bristol-Myers Squibb is to co-develop a new compound to treat cardiovascular disease with Chinese firm Simcere Pharmaceutical Group. The companies, …
Lisa Anson appointed as president of AstraZeneca’s UK marketing
December 15, 2011Business Services, Manufacturing and Production, Medical Communications, Sales and Marketing AstraZeneca, Lisa Anson
AstraZeneca has appointed Lisa Anson as its new president for the firm’s UK marketing company, effective 1 January 2012. Anson …
Optimising your brand – one bite at a time
December 15, 2011Business Services, Medical Communications, Sales and Marketing Alex Blyth, MSI, brand, marketing
Brand managers invest a huge amount of time every year preparing brand plans – but often without really knowing what …
Novartis opens cell-based flu vaccine plant in US
December 15, 2011Manufacturing and Production Novartis, celll-based, vaccines
Novartis has officially started production at a first-of-its kind cell-based manufacturing facility for influenza vaccines in North Carolina, US. The …
Lilly planning new Irish biopharma plant
December 15, 2011Manufacturing and Production lilly, manufactuing
Eli Lilly has filed a planning application to build a new 23,000 sq. m. biologics facility at its manufacturing site …
Boehringer expands manufacturing in China
December 15, 2011Manufacturing and Production Boehringer, China, manufacturing
Boehringer Ingelheim plans to invest €50 million in its manufacturing plant in Shanghai as part of a drive to increase …
Debts will force hospitals to close
December 15, 2011Sales and Marketing NHS, hospitals, king's fund
Around twenty hospitals in England may have to merge or close because of major financial problems, according to a committee …
Roche makes changes in its corporate executive committee
December 15, 2011Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Roche
Roche has made two new appointments in its corporate executive committee. Sophie Kornowski-Bonnet, currently general manager of Roche in France, …
Frazier defends R&D investment and attacks price pressure
December 14, 2011Research and Development, Sales and Marketing Merck, R&D productivity, prices
Merck & Co chief executive Kenneth Frazier has expressed concern that European governments increasingly want to pay unrealistically low prices …
NICE rejects AstraZeneca’s breast cancer drug
December 14, 2011Sales and Marketing AstraZeneca, Faslodex, NICE
NICE has made its final decision not to recommended AstraZeneca’s breast cancer drug Faslodex, as it says the drug is …
NICE gives partial recommendation for RoActemra
December 14, 2011Sales and Marketing RoActemra, Roche
Roche’s patient access scheme has persuaded NICE to recommend RoActemra in childhood arthritis under certain circumstances. In its final guidance …
New cancer drug costs escalating for NHS
December 13, 2011Cancer, NHS, oncology
New oncology drugs are pushing up the overall costs of treating cancer, according to a new report. The ‘Cancer Diagnosis …
GSK’s Stiefel accused of shares fraud
December 13, 2011Sales and Marketing GSK, SEC, Stiefel, fraud
The US financial regulator has charged a subsidiary of GlaxoSmithKline with defrauding staff by buying back shares from them at …
Ian Read elected as chairman of the board at Pfizer
December 13, 2011Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Ian Read, Kindler, Pfizer
Pfizer’s chief executive and president Ian Read has been elected as the firm’s new chairman. Read succeeds George Lorch as …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
